Five-Year Follow-Up After Transcatheter Aortic Valve Implantation in Patients with Severe Aortic Stenosis and Concomitant Coronary Artery Disease: A Single-Center Experience
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 39 (1) , e20220461
Abstract
Introduction: There is no consensus on the impact of coronary artery disease in patients undergoing transcatheter aortic valve implantation. Therefore, the objective of this study was, in a single-center setting, to evaluate the five-year outcome of transcatheter aortic valve implantation patients with or without coronary artery disease.Methods: All transcatheter aortic valve implantation patients between 2009 and 2019 were included and grouped according to the presence or absence of coronary artery disease. The primary endpoint, five-year all-cause mortality, was evaluated using Cox regression adjusted for age, sex, procedure years, and comorbidities. Comorbidities interacting with coronary artery disease were evaluated with interaction tests. In-hospital complications was the secondary endpoint.Results: In total, 176 patients had aortic stenosis and concomitant coronary artery disease, while 170 patients had aortic stenosis only. Mean follow-up was 2.2 +/- 1.6 years. There was no difference in the adjusted five-year all-cause mortality between transcatheter aortic valve implantation patients with and without coronary artery disease (hazard ratio 1.00, 95% confidence interval 0.59-1.70, P=0.99). In coronary artery disease patients, impaired renal function, peripheral arterial disease, or ejection fraction < 50% showed a significant interaction effect with higher five-year all-cause mortality. No significant differences in complications between the groups were found.Conclusion: Five-year mortality did not differ between transcatheter aortic valve implantation patients with or without coronary artery disease. However, in patients with coronary artery disease and impaired renal function, peripheral arterial disease, or ejection fraction < 50%, we found significantly higher five-year all-cause mortality.Keywords
This publication has 25 references indexed in Scilit:
- Transcatheter Aortic Valve Implantation With or Without Percutaneous Coronary Artery Revascularization Strategy: A Systematic Review and Meta‐AnalysisJournal of the American Heart Association, 2017
- Transcatheter aortic valve implantation in patients with a reduced left ventricular ejection fraction: a single-centre experience in 2000 patients (TAVIK Registry)Clinical Research in Cardiology, 2017
- Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk PatientsNew England Journal of Medicine, 2016
- Transcatheter aortic valve implantation in patients with pre-existing chronic kidney diseaseIJC Heart & Vasculature, 2015
- Aortic Stenosis in the ElderlyJACC, 2013
- Coronary Artery Disease and Outcomes of Aortic Valve Replacement for Severe Aortic StenosisJACC, 2013
- The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantationAmerican Heart Journal, 2012
- Clinical Factors Associated With Calcific Aortic Valve DiseaseJACC, 1997
- Development and progression of aortic valve stenosis: Atherosclerosis risk factors—a causal relationship? a clinical morphologic studyClinical Cardiology, 1991
- The natural history of aortic stenosis in adultsAmerican Heart Journal, 1980